Filing Details

Accession Number:
0000711377-17-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-11 18:22:59
Reporting Period:
2017-01-09
Filing Date:
2017-01-11
Accepted Time:
2017-01-11 18:22:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188979 C Jack Parnell Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-09 3,000 $22.75 16,555 No 4 M Direct
Common Stock Acquisiton 2017-01-09 3,000 $28.67 19,555 No 4 M Direct
Common Stock Disposition 2017-01-09 6,000 $66.04 13,555 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-01-09 3,000 $0.00 3,000 $22.75
Common Stock Common Stock (Right to Buy) Disposition 2017-01-09 3,000 $0.00 3,000 $28.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,000 2021-10-06 No 4 M Direct
15,000 2022-10-04 No 4 M Direct
Footnotes
  1. Options were granted 10/6/2011, have ten year lives, and vested in three equal annual installments on the first three anniversary dates of the grant
  2. Options were granted 10/4/2012, have ten year lives, and were fully vested on 10/4/2015